Allurion Technologies, Inc. Deferred Tax Assets, Gross
Allurion Technologies, Inc. (ALUR) had Deferred Tax Assets, Gross of $90.50 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Gross $90.50M.
- 2024-12-31: Deferred Tax Assets, Gross $81.82M.
- 2023-12-31: Deferred Tax Assets, Gross $59.62M.
- 2022-12-31: Deferred Tax Assets, Gross $34.28M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2025-12-31 | $90.50M 10-K · filed 2026-03-30 |
| 2024-12-31 | $81.82M 10-K · filed 2026-03-30 |
| 2023-12-31 | $59.62M 10-K/A · filed 2025-08-28 |
| 2022-12-31 | $34.28M 10-K/A · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |